A CT-based interpretable deep learning signature for predicting PD-L1 expression in bladder cancer: a two-center study.
Journal:
Cancer imaging : the official publication of the International Cancer Imaging Society
PMID:
40065444
Abstract
BACKGROUND: To construct and assess a deep learning (DL) signature that employs computed tomography imaging to predict the expression status of programmed cell death ligand 1 in patients with bladder cancer (BCa).